Send to a Friend Font Size: Increase Decrease

OrbiMed Advisors

OrbiMed Advisors's Portfolio

Last Updated on 5/16/11 @ 11:13am

Ticker	# of Shares	Price	Value
	73,114,592	$195.32	$14,280,742,110
	22,362,850	$195.32	$4,367,911,862
	17,233,668	$195.32	$3,366,080,034
	14,567,176	$195.32	$2,845,260,817
	9,033,726	$195.32	$1,764,467,363
	8,998,338	$195.32	$1,757,555,379
	8,322,140	$195.32	$1,625,480,385
	8,009,729	$195.32	$1,564,460,269
	7,619,135	$195.32	$1,488,169,449
View Additional Portfolio Information »

http://www.orbimed.com/OrbiMed is the world's largest healthcare-dedicated investment firm, with approximately $5 billion in assets under management. The firm was stated in 1989 with a vision to invest across the spectrum of healthcare companies: from private start-ups to large multinational companies.

Login to help us fill in information about this entity.

Form SCHEDULE 13D/A Corvus Pharmaceuticals, Filed by: ORBIMED ADVISORS LLC Jan 27, 2026 08:39PM

Form 4 Corvus Pharmaceuticals, For: Jun 27 Filed by: ORBIMED ADVISORS LLC Jul 1, 2025 09:24PM

Form SCHEDULE 13D/A Corvus Pharmaceuticals, Filed by: ORBIMED ADVISORS LLC May 14, 2025 08:49PM

Form SCHEDULE 13D/A Corvus Pharmaceuticals, Filed by: ORBIMED ADVISORS LLC May 1, 2025 09:21PM

Form 4 Corvus Pharmaceuticals, For: May 06 Filed by: ORBIMED ADVISORS LLC May 8, 2024 08:29PM

May 8, 2024 07:55PM Form SC 13D/A Corvus Pharmaceuticals, Filed by: ORBIMED ADVISORS LLC
Nov 3, 2021 03:04PM Form SC 13D/A Corvus Pharmaceuticals, Filed by: ORBIMED ADVISORS LLC
Sep 22, 2021 05:28PM Form 4 Corvus Pharmaceuticals, For: Sep 20 Filed by: ORBIMED ADVISORS LLC
Sep 22, 2021 05:21PM Form SC 13D/A Corvus Pharmaceuticals, Filed by: ORBIMED ADVISORS LLC
Aug 4, 2021 05:22PM Form SC 13D/A Corvus Pharmaceuticals, Filed by: ORBIMED ADVISORS LLC
Feb 17, 2021 05:09PM Form SC 13D/A Corvus Pharmaceuticals, Filed by: ORBIMED ADVISORS LLC
Oct 5, 2020 07:25AM Corvus Pharmaceuticals (CRVS) Announces Co-Founding of Angel Pharmaceuticals in China
Oct 5, 2020 07:24AM Corvus Pharmaceuticals Announces Co-Founding of Angel Pharmaceuticals in China
Apr 17, 2020 04:14PM Form SC 13D/A Corvus Pharmaceuticals, Filed by: ORBIMED ADVISORS LLC
Aug 8, 2019 04:59PM Form 4 Corvus Pharmaceuticals, For: Aug 06 Filed by: ORBIMED ADVISORS LLC
Jul 2, 2019 04:29PM Form SC 13D/A Corvus Pharmaceuticals, Filed by: ORBIMED ADVISORS LLC
Jul 1, 2019 06:16PM Form 4 Corvus Pharmaceuticals, For: Jun 27 Filed by: ORBIMED ADVISORS LLC
Mar 14, 2018 04:26PM Form SC 13D/A Corvus Pharmaceuticals, Filed by: ORBIMED ADVISORS LLC
Mar 14, 2018 01:59PM Form 4 ORBIMED ADVISORS LLC For: Mar 12 Filed by: Corvus Pharmaceuticals, Inc.
Jan 26, 2018 02:41PM Form SC 13D/A Corvus Pharmaceuticals, Filed by: ORBIMED ADVISORS LLC
Jun 16, 2016 06:00PM Form 4 Corvus Pharmaceuticals, For: Jun 14 Filed by: ORBIMED ADVISORS LLC
Jun 13, 2016 05:18PM Form 4 Corvus Pharmaceuticals, For: Jun 09 Filed by: ORBIMED ADVISORS LLC
May 24, 2016 04:38PM Form 4 Corvus Pharmaceuticals, For: May 20 Filed by: ORBIMED ADVISORS LLC
May 20, 2016 05:22PM Form 4 Corvus Pharmaceuticals, For: May 18 Filed by: ORBIMED ADVISORS LLC
Apr 1, 2016 01:11PM Form SC 13D Corvus Pharmaceuticals, Filed by: ORBIMED ADVISORS LLC
Mar 29, 2016 12:21PM Form 4 Corvus Pharmaceuticals, For: Mar 29 Filed by: ORBIMED ADVISORS LLC

Nasdaq		15000.33
	+57.68	(+0.39%)

S&P 500		4486.55
	+7.02	(+0.16%)

Market Snapshot

Free News Feed